Tepotinib, also known as {MSC2156119|the developmental compound|this molecule), represents a significant breakthrough in the targeting of non-small cell lung tumors, particularly in patients harboring MET changes. This https://tesshgwu178183.wikicorrespondence.com/6592145/tepotinib_a_in_depth_look_into_this_agent_and_its_outlook